MXPA06000539A - Derivado novedoso de heteroarilo. - Google Patents

Derivado novedoso de heteroarilo.

Info

Publication number
MXPA06000539A
MXPA06000539A MXPA06000539A MXPA06000539A MXPA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A
Authority
MX
Mexico
Prior art keywords
substituted
heteroaryl
heteroaryl derivative
novel heteroaryl
formula
Prior art date
Application number
MXPA06000539A
Other languages
English (en)
Spanish (es)
Inventor
Ryu Nagata
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of MXPA06000539A publication Critical patent/MXPA06000539A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
MXPA06000539A 2003-07-15 2004-07-13 Derivado novedoso de heteroarilo. MXPA06000539A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003274684 2003-07-15
PCT/JP2004/010282 WO2005012245A1 (ja) 2003-07-15 2004-07-13 新規ヘテロアリール誘導体

Publications (1)

Publication Number Publication Date
MXPA06000539A true MXPA06000539A (es) 2006-03-30

Family

ID=34113749

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000539A MXPA06000539A (es) 2003-07-15 2004-07-13 Derivado novedoso de heteroarilo.

Country Status (11)

Country Link
US (2) US7425642B2 (https=)
EP (1) EP1647546B1 (https=)
JP (2) JP4820169B2 (https=)
KR (1) KR101086654B1 (https=)
CN (1) CN100516041C (https=)
AT (1) ATE556051T1 (https=)
CA (1) CA2531064C (https=)
ES (1) ES2383895T3 (https=)
MX (1) MXPA06000539A (https=)
TW (1) TW200523249A (https=)
WO (1) WO2005012245A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006075638A1 (ja) * 2005-01-14 2006-07-20 Dainippon Sumitomo Pharma Co., Ltd. 新規ヘテロアリール誘導体
US20060241073A1 (en) * 2005-04-20 2006-10-26 Wanders Ronaldus J A Means and methods for counteracting fatty acid accumulation
TWI386405B (zh) 2006-09-05 2013-02-21 咪唑衍生物
WO2008157537A2 (en) * 2007-06-19 2008-12-24 Ironwood Pharmaceuticals, Inc Compositions and methods of use for treating or preventing lipid related disorders
CN102202662A (zh) * 2008-10-31 2011-09-28 大日本住友制药株式会社 抗糖尿病剂
US20120010264A1 (en) * 2009-03-26 2012-01-12 Dainippon Sumitomo Pharma Co., Ltd. Novel medicament for treating cognitive impairment
WO2011002012A1 (ja) * 2009-07-01 2011-01-06 大日本住友製薬株式会社 Sglt1阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬
KR20120117905A (ko) 2010-01-28 2012-10-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 프로테아좀 활성을 향상시키는 조성물 및 방법
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
HUE044867T2 (hu) 2011-05-12 2019-11-28 Proteostasis Therapeutics Inc Proteosztázis szabályzók
US10266490B2 (en) * 2012-03-16 2019-04-23 Georgetown University Radioprotector compounds
US9849135B2 (en) 2013-01-25 2017-12-26 President And Fellows Of Harvard College USP14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752361A1 (de) * 1977-11-24 1979-06-07 Troponwerke Gmbh & Co Kg Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0973778A1 (en) * 1997-03-07 2000-01-26 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
EP1284260A4 (en) 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd TYROSIN PHOSPHATASE INHIBITORS
JP2002121186A (ja) * 2000-05-22 2002-04-23 Takeda Chem Ind Ltd チロシンホスファターゼ阻害剤
ATE423120T1 (de) * 2000-06-26 2009-03-15 Pfizer Prod Inc Pyrroloä2,3-düpyrimidin verbindungen als immunosuppressive wirkstoffe
EP1386913B1 (en) * 2001-04-19 2008-07-16 Dainippon Sumitomo Pharma Co., Ltd. Pyrrole derivative
JP2003171275A (ja) 2001-12-11 2003-06-17 Sumitomo Pharmaceut Co Ltd PPARδアゴニスト
JPWO2004048341A1 (ja) 2002-11-28 2006-03-23 住友製薬株式会社 新規ヘテロアリール誘導体

Also Published As

Publication number Publication date
CN1849303A (zh) 2006-10-18
JP2011251974A (ja) 2011-12-15
TWI331142B (https=) 2010-10-01
KR20060040681A (ko) 2006-05-10
EP1647546A1 (en) 2006-04-19
US20060194857A1 (en) 2006-08-31
US7425642B2 (en) 2008-09-16
US20080306275A1 (en) 2008-12-11
WO2005012245A1 (ja) 2005-02-10
JPWO2005012245A1 (ja) 2006-09-14
CN100516041C (zh) 2009-07-22
CA2531064A1 (en) 2005-02-10
TW200523249A (en) 2005-07-16
JP4820169B2 (ja) 2011-11-24
CA2531064C (en) 2012-05-22
ATE556051T1 (de) 2012-05-15
EP1647546A4 (en) 2008-07-23
KR101086654B1 (ko) 2011-11-24
ES2383895T3 (es) 2012-06-27
HK1087409A1 (en) 2006-10-13
EP1647546B1 (en) 2012-05-02

Similar Documents

Publication Publication Date Title
MXPA06000539A (es) Derivado novedoso de heteroarilo.
EP1674452A4 (en) NEW 4-PHENYLAMINOBENZALDOXIMDERIVATIE AND ITS USE AS MEK INHIBITOR
GEP20094676B (en) Piperidine compounds and pharmaceutical compositions containing them
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
IN2014DN02278A (https=)
ATE417049T1 (de) Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
NO20034660D0 (no) Spiropyrazolforbindelser
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MXPA03011050A (es) Conjugados de lipido-polimero.
DE60027144D1 (de) Hydroxamsäure-derivate
MY138826A (en) 2,7-substituted indoles
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
TR200100961T2 (tr) İzosorbid mononitrat türevleri ve bunların azaltılmış toleranslı damar genişletici olarak kullanılması
WO2006066020A3 (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
GB2436996B (en) Rigid amines
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
MXPA05005198A (es) Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina.
WO2007056091A3 (en) 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
WO2004000793A3 (en) Aminoacetonitrile derivatives suitable for controlling parasites
WO2005005461A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
PT1204659E (pt) Benzofuranos serotoninergicos
NO20051282L (no) Antitumorale analoger av lamellariner.
EP1221445A4 (en) PENTACYCLIC TAXAN COMPOUNDS
WO2005060981A3 (en) Pharmaceutical compositions
DE602004013766D1 (de) Härtbare polymerverbindung

Legal Events

Date Code Title Description
FG Grant or registration